査読有
doi：10.1111/hepr.70023
PubMed No.：40838970
2024 Impact Factor：3.4
種類：原著
誌名：Hepatology Research
発行年月：2025年8月
巻号頁：in press
論題：Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study
著者：Takeshi Hatanaka, Shigeo Shimose, Takanori Ito, Joji Tani, Tetsu Tomonari, Issei Saeki, Yasuto Takeuchi, Kyo Sasaki, Yuichi Honma, Ryu Sasaki, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Satoshi Itano, Yuki Kanayama, Tomotake Shirono, Norikazu Tanabe, Takafumi Yamamoto, Atsushi Naganuma, Sohji Nishina, Motoyuki Otsuka, Hideki Kobara, Taro Takami, Tetsuji Takayama, Takumi Kawaguchi, Hiroki Kawashima, Masaru Harada, Hisamitsu Miyaaki, Satoru Kakizaki; Hepatology InVestigator Experts in Japan (HIVE‐J) Study Group
